Immunovia detects pancreatic cancer with a blood test

The test is initially targeted at risk groups. Pancreatic cancer took my father, so I would gladly go for that test even once a year.

There are enough people in risk groups in the world, and the company is only worth about 20 million euros so far.

1 Like